Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Taf Tdf'

Taf Tdf published presentations and documents on DocSlides.

Phase 2 of new ARVs

Phase 2 of new ARVs

  • mitsue-stanley
  • 18 Slides

Fostemsavir. , . prodrug. of . temsavir. . (. a...

State

State

  • pasty-toler
  • 49 Slides

of the evidence from oral and topical . PrEP. ef...

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

  • marina-yarberry
  • 41 Slides

An HIV pre-exposure prophylaxis trial in Thailand...

Tenofovir

Tenofovir

  • alida-meadow
  • 101 Slides

based . PrEP. technologies in women : . what do...

1 Adam O’Neill Leonid

1 Adam O’Neill Leonid

  • celsa-spraggs
  • 137 Slides

Reyzin. Boston University. . A Unified Approach ...

Overview of HIV Epidemiology and Prevention Sciences for ke

Overview of HIV Epidemiology and Prevention Sciences for ke

  • alida-meadow
  • 23 Slides

Stefan Baral, MD MPH FRCPC. Center for Public Hea...

The Evidence

The Evidence

  • danika-pritchard
  • 36 Slides

– . PrEP. Effectiveness. Module . 1(b). The Ev...

HBV resistance and

HBV resistance and

  • calandra-battersby
  • 21 Slides

immune escape . mutants. Anders Boyd, MPH, . PhD....

Switch to DRV/r + RAL

Switch to DRV/r + RAL

  • debby-jeon
  • 5 Slides

SPARE . Study. SPARE Study: switch to DRV/r + RAL...

Comparison of NNRTI vs NNRTI

Comparison of NNRTI vs NNRTI

  • tatyana-admore
  • 12 Slides

ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...

NRTI-sparing

NRTI-sparing

  • liane-varnes
  • 6 Slides

SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...

Switch to EVG/c/FTC/TDF

Switch to EVG/c/FTC/TDF

  • liane-varnes
  • 9 Slides

STRATEGY-PI . Study. STRATEGY-NNRTI . Study. Desi...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • cheryl-pisano
  • 9 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....

P1084s: Impact of maternal

P1084s: Impact of maternal

  • olivia-moreira
  • 0 Slides

tenofovir. . disoproxil. . fumarate. (TDF) . u...

Tyre Stewardship in Canada

Tyre Stewardship in Canada

  • sherrill-nordquist
  • 0 Slides

Presented to . New Zealand . Tyre. Industry Summ...

Eric S. Daar , MD Professor of Medicine

Eric S. Daar , MD Professor of Medicine

  • faustina-dinatale
  • 0 Slides

David Geffen School of Medicine. at University of...

Michael S. Saag , MD Eric S.

Michael S. Saag , MD Eric S.

  • pamella-moone
  • 0 Slides

Daar. , MD. Antiretroviral Therapy:. A Case-Based...

The Evidence – PrEP Effectiveness

The Evidence – PrEP Effectiveness

  • lindy-dunigan
  • 0 Slides

Module . 1(b). The Evidence in Detail. Session Ov...

Clinical Management Module

Clinical Management Module

  • stefany-barnette
  • 0 Slides

4. . (b) . Risks and Side Effects. Overview. Res...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • liane-varnes
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

ART Initiation: PrEP and

ART Initiation: PrEP and

  • alida-meadow
  • 0 Slides

Treatment-naïve Patients . Clinical Instructor, ...

Fixed-Dose Combination of

Fixed-Dose Combination of

  • myesha-ticknor
  • 0 Slides

Doravirine. /Lamivudine/TDF is Non-Inferior to . ...

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention

  • pamella-moone
  • 0 Slides

Efficacy and the importance of adherence. Joanne ...

HIV Medicine From Guidelines to Practice

HIV Medicine From Guidelines to Practice

  • cheryl-pisano
  • 0 Slides

Kiat. . Ruxrungtham. Professor of Medicine, . Ch...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-

Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-

  • min-jolicoeur
  • 0 Slides

implementation of Dolutegravir. Meireles MV. , Pa...

What’s Next – and When:

What’s Next – and When:

  • sherrill-nordquist
  • 0 Slides

An Update on Injectable . P. revention. Alex R Ri...

Eric S. Daar , MD Professor of Medicine

Eric S. Daar , MD Professor of Medicine

  • faustina-dinatale
  • 0 Slides

David Geffen School of Medicine. at University of...

How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN

How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN

  • tawny-fly
  • 0 Slides

Sinead Delany-Moretlwe. Wits RHI, University of t...

Comparison of NNRTI vs NNRTI

Comparison of NNRTI vs NNRTI

  • lindy-dunigan
  • 0 Slides

ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

  • kittie-lecroy
  • 32 Slides

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

  • giovanna-bartolotta
  • 13 Slides

“On Demand” Oral PrEP: Lessons Learned from M...

Gilead Sciences, Inc., Foster City, CA, USA

Gilead Sciences, Inc., Foster City, CA, USA

  • phoebe-click
  • 19 Slides

Gilead Sciences, Inc., Foster City, CA, USA FTC/T...

Common Pharmacomistakes in Advanced Illness

Common Pharmacomistakes in Advanced Illness

  • tawny-fly
  • 42 Slides

Common Pharmacomistakes in Advanced Illness Opioi...

CROI Update: Best of Boston

CROI Update: Best of Boston

  • triclin
  • 54 Slides

p. resented by. NCATEC. March . 18, . 2014. David ...

HIV Medicine From Guidelines to Practice

HIV Medicine From Guidelines to Practice

  • jubilantbikers
  • 63 Slides

Kiat. . Ruxrungtham. Professor of Medicine, . Chu...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Comparison of RTV vs Cobi

Comparison of RTV vs Cobi

  • studmonkeybikers
  • 11 Slides

GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...

937401234123534671341849346744x 19 333133Webinar Requirements A c

937401234123534671341849346744x 19 333133Webinar Requirements A c

  • erica
  • 72 Slides

HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...

Target Date Funds and P

Target Date Funds and P

  • unita
  • 12 Slides

lan . S. ponsor Responsibilities. Marcia S. Wagner...

Copyright © 2024 DocSlides. All Rights Reserved